Brivaracetam Impurity 209 CAS CATO-C4X-2007209

Purity 97%+In StockPharmacopoeial Impurity Standards
CAS No.CATO-C4X-2007209
Molecular FormulaC7H13KO3
Molecular Weight184.27 g/mol
CategoryPharmacopoeial Impurity Standards / EP Impurities
AvailabilityIn Stock

Chemical Structure

Brivaracetam Impurity 209 CAS CATO-C4X-2007209 chemical structure

Description

Under current pharmacopoeial and regulatory frameworks, quality-control requirements for this class of reference material explicitly involve the control of targets including Brivaracetam Impurity 209.

As a process- or degradation-related impurity, Brivaracetam Impurity 209 (CAS CATO-C4X-2007209, C7H13KO3) is essential for impurity profiling, related-substances testing, and forced-degradation studies in pharmaceutical development.

Structurally, Brivaracetam Impurity 209 (C7H13KO3) contains a carboxylic acid group, a hydroxyl group, an ether linkage. The molecule exhibits a degree of unsaturation (DBE) of 1.5, corresponding to approximately 1 ring(s) or double-bond equivalent(s). With a molecular weight of 184.27 g/mol, it falls into the medium-molecular-weight range.

Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.

CATO manufactures Brivaracetam Impurity 209 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.

Physical & Chemical Properties

Molecular FormulaC7H13KO3
Molecular Weight184.27 g/mol
Purity97%+
StorageStore at 2-8°C, keep sealed and dry
Solubility (reference)Soluble in methanol, ethanol, DMSO, water
StabilityHygroscopic; reseal immediately after opening
Degree of Unsaturation (DBE)1.5

Related Brivaracetam Standards

Recommended Standards

Why CATO?